TW200722080A - Dosing regimen - Google Patents

Dosing regimen

Info

Publication number
TW200722080A
TW200722080A TW095116960A TW95116960A TW200722080A TW 200722080 A TW200722080 A TW 200722080A TW 095116960 A TW095116960 A TW 095116960A TW 95116960 A TW95116960 A TW 95116960A TW 200722080 A TW200722080 A TW 200722080A
Authority
TW
Taiwan
Prior art keywords
dosing regimen
tert
drug
deberlzoyl
dephenyl
Prior art date
Application number
TW095116960A
Other languages
English (en)
Inventor
Maurizio Voi
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of TW200722080A publication Critical patent/TW200722080A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW095116960A 2005-05-13 2006-05-12 Dosing regimen TW200722080A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68069805P 2005-05-13 2005-05-13

Publications (1)

Publication Number Publication Date
TW200722080A true TW200722080A (en) 2007-06-16

Family

ID=37432028

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095116960A TW200722080A (en) 2005-05-13 2006-05-12 Dosing regimen

Country Status (2)

Country Link
TW (1) TW200722080A (zh)
WO (1) WO2006124884A2 (zh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0101457A3 (en) * 1997-12-31 2003-01-28 Bristol Myers Squibb Co Antitumor 2-aroyl-4-acyl paclitaxel analogs and medicaments containing them , their intermediates and method for producing them
US6515004B1 (en) * 1999-12-15 2003-02-04 Bristol-Myers Squibb Company N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases

Also Published As

Publication number Publication date
WO2006124884A3 (en) 2007-04-19
WO2006124884A2 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
UA105210C2 (ru) Противораковая вакцина и ее применение
UA94734C2 (ru) ТЕРАПЕВТИЧЕСКОЕ АНТИТЕЛО, КОТОРОЕ СВЯЗЫВАЕТСЯ С b-АМИЛОИДНЫМ ПЕПТИДОМ
TWI315203B (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
HK1100480A1 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
IL149147A0 (en) Use of oxcarbazepine for the manufacture of oral dosage form medicament
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
IL193094A (en) Appalidine and other drugs used in the manufacture of a cancer treatment drug when the combination of the two gives a synergistic result
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
HUP0401174A3 (en) Ecteinascidin analogues, their use in the preparation of a medicament for treatment of cancer and pharmaceutical compositions containing the compounds
MXPA06013133A (es) Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina.
HK1105886A1 (zh) 含有 的治療癌腫瘤的藥物組合物
NZ628513A (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
EP1658105A4 (en) AEROSOL-PHARMACEUTICAL DOSER AND ASSOCIATED METHODS
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
TN2009000119A1 (en) Combination drug
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
HK1100352A1 (en) Solid medicament of oral administration and preparation thereof
EP1654312A4 (en) PHARMACEUTICAL DOSING INHALER AND RELATED METHODS
TW200611697A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
TW200722080A (en) Dosing regimen
MXPA05009849A (es) Terapia combinada que comprende nemorubicina y un inhibidor de la ciclooxigenasa-2.
HK1084879A1 (en) Use of a pharmaceutical composition to prepare the medicament for increasing therapeutic gain in radiotherapy and chemotherapy
TW200633722A (en) Complexes made using low solubility drugs
WO2005011589A3 (en) Drug delivery methods and devices